David Roth has been a faculty member of the University of Miami Miller School of Medicine since 1982. Since that time he has committed the majority of his clinical activities to building the kidney transplantation program into one of the preeminent programs in the United States. This program, which is now a part of the more prominent Miami Transplant Institute, provides life-saving kidney transplantation to over 300 patients each year with end-stage renal disease who come to Miami from around the state and the country.
Over the three decades of his career at the University of Miami Dr. Roth has maintained an active interest in clinical research. Most of this work has focused on immunosuppressive protocols in kidney transplantation and the impact of hepatitis C virus infection on the kidney transplant candidate and recipient. Dr. Roth was also honored to have been the Co-Chair of the Kidney Disease in Global Outcomes study group on Hepatitis C Virus in Kidney Disease. This international group of experts published the first KDIGO Guideline focused on this topic.